5/24/17
The Morbidity and Mortality Weekly report dated May 9th 2017 includes the updated Trumenba dosing recommendations of the Advisory Committee on Immunization Practices. The ACIP recommends the 2-dose schedule of Trumenba when given to healthy adolescents and young adults, aged 16 through 23 years, who are not at increased risk for meningococcal disease, as a category B recommendation.